Medicines which can be used to treat lymphoma, lung cancer, breast cancer and psoriasis have been accepted by the Scottish Medicines Consortium (SMC) for use by NHSScotland.
The Scottish Medicines Consortium has approved five medicines for use in NHS Scotland.
Following consideration through PACE, the committee was unable to accept two medicines for the treatment of cystic fibrosis, an inherited disease that has severe effects on the lungs and the digestive system.
The Scottish Medicines Consortium (SMC), which advises on newly licensed medicines for use by NHSScotland, has published advice accepting five new medicines. Benralizumab (Fasenra) was accepted for the treatment of severe eosinophilic asthma (a type of asthma characterised by an excess of inflammatory cells known as eosinophils) which is not well controlled with […]